Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Plos One
|
October 21, 2015
Analysis of the DNA-Binding Activities of the Arabidopsis R2R3-MYB Transcription Factor Family by One-Hybrid Experiments in Yeast
Zsolt Kelemen, Alvaro Sebastian, Wenjia Xu, et al.
Nature Methods
|
November 17, 2020
Avant-garde: an automated data-driven DIA data curation tool
Alvaro Sebastian Vaca Jacome, Ryan Peckner, Nicholas Shulman, et al.
Molecular & Cellular Proteomics : MCP
|
May 4, 2023
Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry
Kshiti Meera Phulphagar, Claudia Ctortecka, Alvaro Sebastian Vaca Jacome, et al.
Molecular & Cellular Proteomics : MCP
|
January 9, 2025
High-Throughput Determination of Exchange Rates of Unmodified and PTM-Containing Peptides Using HX-MS
Jamie A Moroco, Alvaro Sebastian Vaca Jacome, Pierre Michel Jean Beltran, et al.
Molecular Cell
|
October 7, 2022
Calcineurin dephosphorylates topoisomerase IIβ and regulates the formation of neuronal-activity-induced DNA breaks
Ilse Delint-Ramirez, Lahiri Konada, Lance Heady, et al.
Patterns (New York, N.Y.)
|
June 28, 2021
Causal interactions from proteomic profiles: Molecular data meet pathway knowledge
Özgün Babur, Augustin Luna, Anil Korkut, et al.
Annals of the Rheumatic Diseases
|
July 22, 2018
Multi-OMICS analyses unveil <i>STAT1</i> as a potential modifier gene in mevalonate kinase deficiency
Raphael Carapito, Christine Carapito, Aurore Morlon, et al.
Scientific Data
|
August 26, 2021
Proteomic profiling dataset of chemical perturbations in multiple biological backgrounds
Deborah O Dele-Oni, Karen E Christianson, Shawn B Egri, et al.
Cancer Immunology Research
|
November 14, 2025
The allogeneic FAP-CAR-IL15 iNKT therapy MiNK-215 remodels the tumor stroma to enhance antitumor immunity
Eleni Chantzoura, Efrat Altman-Sharoni, Xavier Michelet, et al.
Cancer Discovery
|
July 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy
Dhan Chand, David A Savitsky, Shanmugarajan Krishnan, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Plos One
|
October 21, 2015
Analysis of the DNA-Binding Activities of the Arabidopsis R2R3-MYB Transcription Factor Family by One-Hybrid Experiments in Yeast
Zsolt Kelemen, Alvaro Sebastian, Wenjia Xu, et al.
Nature Methods
|
November 17, 2020
Avant-garde: an automated data-driven DIA data curation tool
Alvaro Sebastian Vaca Jacome, Ryan Peckner, Nicholas Shulman, et al.
Molecular & Cellular Proteomics : MCP
|
May 4, 2023
Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry
Kshiti Meera Phulphagar, Claudia Ctortecka, Alvaro Sebastian Vaca Jacome, et al.
Molecular & Cellular Proteomics : MCP
|
January 9, 2025
High-Throughput Determination of Exchange Rates of Unmodified and PTM-Containing Peptides Using HX-MS
Jamie A Moroco, Alvaro Sebastian Vaca Jacome, Pierre Michel Jean Beltran, et al.
Molecular Cell
|
October 7, 2022
Calcineurin dephosphorylates topoisomerase IIβ and regulates the formation of neuronal-activity-induced DNA breaks
Ilse Delint-Ramirez, Lahiri Konada, Lance Heady, et al.
Patterns (New York, N.Y.)
|
June 28, 2021
Causal interactions from proteomic profiles: Molecular data meet pathway knowledge
Özgün Babur, Augustin Luna, Anil Korkut, et al.
Annals of the Rheumatic Diseases
|
July 22, 2018
Multi-OMICS analyses unveil <i>STAT1</i> as a potential modifier gene in mevalonate kinase deficiency
Raphael Carapito, Christine Carapito, Aurore Morlon, et al.
Scientific Data
|
August 26, 2021
Proteomic profiling dataset of chemical perturbations in multiple biological backgrounds
Deborah O Dele-Oni, Karen E Christianson, Shawn B Egri, et al.
Cancer Immunology Research
|
November 14, 2025
The allogeneic FAP-CAR-IL15 iNKT therapy MiNK-215 remodels the tumor stroma to enhance antitumor immunity
Eleni Chantzoura, Efrat Altman-Sharoni, Xavier Michelet, et al.
Cancer Discovery
|
July 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy
Dhan Chand, David A Savitsky, Shanmugarajan Krishnan, et al.
Page
of 4